Calendar Recursion Pharmaceuticals, Inc.

Equities

RXRX

US75629V1044

Market Closed - Nasdaq 04:00:00 2024-07-12 pm EDT 5-day change 1st Jan Change
8.36 USD +8.85% Intraday chart for Recursion Pharmaceuticals, Inc. +14.21% -15.21%

Chart calendar Recursion Pharmaceuticals, Inc.

a84ac3e8a7008384fd68213d46a68af.njdnx0-9wCJBQdcfI6uMyOSja4ZaLqWXQY2JcU1id2s.-3YP_gH8jFAZcLJMTeK4u5GaPM82ZsTILPnuEwwNHzGvUSaXIdy5ejMGgg~1dcd84e9bddff548e7ac20f47d6e4795

Upcoming events on Recursion Pharmaceuticals, Inc.

2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-05 Q3 2024 Earnings Release (Projected)
2025-03-03 Q4 2024 Earnings Release (Projected)
2025-05-06 Q1 2025 Earnings Release (Projected)

Past events on Recursion Pharmaceuticals, Inc.

2024-06-25 Morgan Stanley Life Sciences AI Summit
2024-06-09 Goldman Sachs Global Healthcare Conference
2024-06-05 10:30 am Jefferies Global Healthcare Conference
2024-06-03 10:00 am Annual General Meeting
2024-05-20 02:30 pm J.P. Morgan Global Technology, Media and Communications Conference
2024-05-14 06:00 pm BofA Securities Health Care Conference
2024-05-09 05:00 pm Q1 2024 Earnings Call
2024-05-09 04:01 pm Q1 2024 Earnings Release
2024-04-08 10:15 am Needham Healthcare Conference
2024-03-18 KeyBanc Life Sciences & MedTech Forum
2024-03-11 02:00 pm Leerink Partners Global Biopharma Conference
2024-03-05 02:00 pm KeyBanc Emerging Technology Summit
2024-03-04 04:25 pm Morgan Stanley Technology, Media & Telecom Conference
2024-02-27 05:00 pm Q4 2023 Earnings Call
2024-02-27 04:05 pm Q4 2023 Earnings Release
2024-01-16 09:30 am Needham Growth Conference
2024-01-08 10:30 am JPMorgan Healthcare Conference
2023-11-14 03:00 am Jefferies London Healthcare Conference
2023-11-09 07:58 am Q3 2023 Earnings Release
2023-09-27 09:30 am Goldman Sachs Global Sustainability Forum

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
3,96


10,2
12,4
-17.66%
39,8
51,2
-22.25%
44,6
52,1
-14.47%

58,3

EBITDA
Million USD
Released
Forecast
Spread
0,00


-174
-175
0.11%
-234
-256
8.74%
-326
-307
-6%

-410

EBIT
Million USD
Released
Forecast
Spread
0,00


-183
-174
-4.89%
-246
-227
-8.46%
-350
-342
-2.41%

-421

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-186
-163
-14.4%
-239
-216
-11.13%
-332
-329
-0.81%

-392

Net income
Million USD
Released
Forecast
Spread
-87,0


-186
-177
-5.45%
-239
-226
-6.11%
-328
-333
1.49%

-384

EPS
USD
Released
Forecast
Spread
-5,99


-1,49
-1,20
-24.25%
-1,36
-1,39
2.44%
-1,58
-1,66
5.01%

-1,62

Announcement Date03/03/2123/03/2227/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
5,33
84,0
-93.65%
7,67
5,40
42.11%
13,2
6,85
92.12%
13,7
24,0
-43.02%
12,1
13,2
-7.75%
11,0
11,9
-7.54%
10,5
12,9
-18.16%
10,9
20,4
-46.49%
13,8
13,1
5.57%

13,3


13,4


16,1


12,2


10,3

EBITDA
Million USD
Released
Forecast
Spread






-59,6
-75,0
20.55%



-66,1
-113
41.21%
-76,2
-63,7
-19.58%



-91,4
-85,5
-6.87%

-91,3


-89,0


-88,3


-182


-199


-203

EBIT
Million USD
Released
Forecast
Spread
-56,0
-52,0
-7.66%
-66,2
-65,6
-0.92%
-62,6
-66,9
6.5%
-61,0
-49,8
-22.52%
-69,9
-63,0
-10.89%
-81,7
-73,1
-11.82%
-99,6
-81,9
-21.57%
-98,9
-87,9
-12.52%
-96,3
-100
3.73%

-101


-110


-111


-101


-101

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread



-65,6
-57,0
-15.02%
-60,4
-61,0
0.91%
-57,5
-13,0
-342.25%
-65,3
-62,0
-5.37%
-76,7
-69,0
-11.2%
-93,0
-82,0
-13.44%
-94,6
-94,4
-0.24%
-92,2
-106
13.06%

-84,0


-85,2


-84,0


-79,4


-86,9

Net income
Million USD
Released
Forecast
Spread
-56,0
87,3
-164.12%
-65,6
-60,6
-8.27%
-60,4
-63,1
4.21%
-57,5
-45,9
-25.25%
-65,3
-60,2
-8.48%
-76,7
-70,6
-8.62%
-93,0
-77,5
-20.01%
-93,0
-96,7
3.87%
-91,4
-98,9
7.63%

-91,7


-92,3


-112


-129


-133

EPS
USD
Released
Forecast
Spread
-0,33
0,51
-164.71%
-0,38
-0,35
-10.1%
-0,35
-0,36
3.22%
-0,30
-0,25
-20%
-0,34
-0,34
-0.43%
-0,38
-0,37
-3.55%
-0,43
-0,38
-12.99%
-0,42
-0,45
6.69%
-0,39
-0,42
6.25%

-0,38


-0,37


-0,42


-0,53


-0,54

Announcement Date10/05/2209/08/2208/11/2227/02/2308/05/2308/08/2309/11/2327/02/2409/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RXRX Stock
  4. Calendar Recursion Pharmaceuticals, Inc.